Senzime
Manufacturing · Sweden · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Ulls Väg 41, Uppsala, Uppsala, 756 51, S...Phone Number
+46 18515640Website
www.senzime.comRevenue
$11.2 MillionStock Symbol
SEZI.STIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Senzime
Senzime develops and markets CE- and FDA cleared patient monitoring systems driven by unique algorithms and sensors to closely monitor patients under anesthesia. TetraGraph is a system that digitally and continuously measures the degree of neuromuscular blockade in the patient. The goal is improved clinical precision and simplified management in healthcare. By preventing complications and enabling healthcare professionals to follow guidelines and drug recommendations, TetraGraph can contribute to shorten hospital stays and lower healthcare costs. The vision is a world without anesthesia related complications, where everyone wakes up safely after surgery. Senzime operates in growing markets that in Europe and the United States are valued in excess of SEK 15 billion.Explore more
Senzime Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Senzime your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Senzime launches new products
Earning: See what the market has to say on Senzime recently announced quarterly report
Check out if Senzime is spiking on competitors!
Check if Senzime has recently received funding, and reach out quickly before it becomes old news!
Click to see if Senzime had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Senzime
Senzime, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Senzime has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Senzime
Find 2 more new buyers
Company Profile Activity
Activity Insights
Senzime is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Senzime is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Senzime.
Senzime financials insights
Gather financial insights about Senzime, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$1.1M
2016
Private Equity
$7.1M
Senzime Tech Stack
A closer look at the technologies used by Senzime
See more technologies
Most Recent Scoops
Partnership
Senzime has partnered with Philips to jointly develop a portfolio of products based on each company's proprietary technologies, with Senzime leading development and manufacturing, in an agreement expected to significantly expand Senzime's market reach into new segments over the medium to long term.
Partnership, Product Development
Product Launch
Senzime has announced the launch of TetraAnalytics, a cloud-based, AI-ready analytics software that visualizes data from TetraGraph systems to generate clinical insights, monitor compliance with clinical guidelines, and drive utilization across healthcare facilities.
Cloud, Product Launch
Product Launch
Senzime has announced the launch of a new TetraSens sensor, a European-manufactured disposable sensor designed with a minimal environmental footprint using novel production technologies, offering improved unit economics and targeting growing demand for sustainable operating room products, particularly among European accounts.
Product Launch, Sustainability
Earnings
Senzime has reported a 27% improvement in EBITDA and a 46% improvement in cash flow for Q2, alongside a 15% decrease in operating expenses, despite a near-zero-growth quarter driven by continued market headwinds for new monitor sales, particularly in the US market.
Earnings, Accounting, Financial Reporting, Business Finance, Finance
Project
Partnership, Business Development
Senzime News & Media
Senzime AB (publ) (SNZZF) Q2 2026 Earnings Call Prepared Remarks Transcript
Senzime AB (publ) (SNZZF) Q2 2026 Earnings Call July 16, 2026 3:00 AM EDTCompany ParticipantsPhilip Siberg - Chief Executive OfficerPresentationPhilip...Fukuda Denshi USA Announces Availability of Senzime’s Next-Generation TetraGraph® Neuromuscular Monitoring System
Advanced quantitative EMG monitoring solutions from Senzime are now available through Fukuda Denshi USA to support safer anesthesia care. REDMOND, WA, UNITED STATES, June 1, 2026 /EINPresswire.com/ -- Fukuda Denshi USA, Inc. today announced the …Senzime AB (publ) (SNZZF) Q1 2026 Earnings Call Transcript
Senzime AB (publ) (SNZZF) Q1 2026 Earnings Call April 22, 2026 5:00 AM EDTCompany ParticipantsPhilip Siberg - Chief Executive OfficerConference Call...Senzime AB (publ) (SNZZF) Q1 2026 Earnings Call Prepared Remarks Transcript
Senzime AB (publ) (SNZZF) Q1 2026 Earnings Call April 22, 2026 3:00 AM EDTCompany ParticipantsPhilip Siberg - Chief Executive OfficerPresentationPhilip...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Senzime
Sign Up For FreeTo access detailed company insights
Senzime develops and markets CE- and FDA cleared patient monitoring systems driven by unique algorithms and sensors to closely monitor patients under anesthesia. TetraGraph is a system that digitally and continuously measures the degree of neuromuscular blockade in the patient. The goal is improved clinical precision and simplified management in he... Read More
